ArticleDrug design, development and therapy2023

Liquiritin Protects Against Cardiac Fibrosis After Myocardial Fibrosis After Myocardial Infarction by Inhibiting CCL5 Expression and the NF-κB Signaling Pathway [Letter].

Hasta Handayani Idrus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.